Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study.
Chen QY, Guo SS, Luo Y, Qu S, Wu DH, Chen XZ, Chen DP, Qin XT, Lin Q, Jin F, Lin SJ, Yao ZF, Liu W, Maxwell Wang Z, Li BY, Xia M, Xu RH, Tang LQ, Mai HQ.
Chen QY, et al. Among authors: wu dh.
Oral Oncol. 2024 Apr;151:106723. doi: 10.1016/j.oraloncology.2024.106723. Epub 2024 Feb 22.
Oral Oncol. 2024.
PMID: 38387261
Clinical Trial.